152 related articles for article (PubMed ID: 37436377)
21. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
[No Abstract] [Full Text] [Related]
22. Evaluating the clinical performance of
Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
[TBL] [Abstract][Full Text] [Related]
23. A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.
Dai Y; Zhao G; Yang J; Zhou X; Xiong S; Lu X; Gao L; Wu J; Xu Z; Fei S; Zheng M; Xu H
BMC Gastroenterol; 2022 Oct; 22(1):428. PubMed ID: 36203138
[TBL] [Abstract][Full Text] [Related]
24. Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms.
Zeng T; Huang Z; Yu X; Zheng L; Liu T; Tian B; Xiao S; Huang J
Front Oncol; 2023; 13():1166796. PubMed ID: 37621691
[TBL] [Abstract][Full Text] [Related]
25. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
26. Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population.
Jiang HH; Xing SW; Tang X; Chen Y; Lin K; He LW; Lin MB; Tang EJ
World J Gastroenterol; 2022 Jun; 28(24):2705-2732. PubMed ID: 35979157
[TBL] [Abstract][Full Text] [Related]
27. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract][Full Text] [Related]
28. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis.
Wang L; Liu Y; Zhang D; Xiong X; Hao T; Zhong L; Zhao Y
BMC Gastroenterol; 2022 Jun; 22(1):314. PubMed ID: 35754025
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
31. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
32. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
33. Quantitative detection of SRY-Box 21 (
Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
[TBL] [Abstract][Full Text] [Related]
34. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
[TBL] [Abstract][Full Text] [Related]
35. Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Li R; Qu B; Wan K; Lu C; Li T; Zhou F; Lin J
FEBS Open Bio; 2021 Jul; 11(7):1941-1952. PubMed ID: 33955718
[TBL] [Abstract][Full Text] [Related]
36. Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.
Liu YM; Peng L; Chen C; Zhou P; Cheng B; Luo Y; Zhou MF; Xuan SX; Lin JD; Yin WG
Ann Med; 2023; 55(2):2261111. PubMed ID: 37783044
[TBL] [Abstract][Full Text] [Related]
37. Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer.
Song JH; Oh TJ; An S; Lee KH; Kim JY; Kim JS
World J Gastrointest Surg; 2023 Sep; 15(9):2032-2041. PubMed ID: 37901726
[TBL] [Abstract][Full Text] [Related]
38. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
39. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]